The Role of Low-Energy Electron Interactions in cis-Pt(CO)2Br2 Fragmentation

Int J Mol Sci. 2021 Aug 20;22(16):8984. doi: 10.3390/ijms22168984.

Abstract

Platinum coordination complexes have found wide applications as chemotherapeutic anticancer drugs in synchronous combination with radiation (chemoradiation) as well as precursors in focused electron beam induced deposition (FEBID) for nano-scale fabrication. In both applications, low-energy electrons (LEE) play an important role with regard to the fragmentation pathways. In the former case, the high-energy radiation applied creates an abundance of reactive photo- and secondary electrons that determine the reaction paths of the respective radiation sensitizers. In the latter case, low-energy secondary electrons determine the deposition chemistry. In this contribution, we present a combined experimental and theoretical study on the role of LEE interactions in the fragmentation of the Pt(II) coordination compound cis-PtBr2(CO)2. We discuss our results in conjunction with the widely used cancer therapeutic Pt(II) coordination compound cis-Pt(NH3)2Cl2 (cisplatin) and the carbonyl analog Pt(CO)2Cl2, and we show that efficient CO loss through dissociative electron attachment dominates the reactivity of these carbonyl complexes with low-energy electrons, while halogen loss through DEA dominates the reactivity of cis-Pt(NH3)2Cl2.

Keywords: anticancer drugs; cisplatin; dissociative electron attachment; dissociative ionization; focused electron beam induced deposition; low-energy electrons; platinum (II) halo-carbonyl complexes.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Bromides / chemistry*
  • Bromides / pharmacology
  • Cisplatin / pharmacology
  • Coordination Complexes / chemistry*
  • Electrons
  • Platinum
  • Platinum Compounds / chemistry*
  • Platinum Compounds / pharmacology

Substances

  • Antineoplastic Agents
  • Bromides
  • Coordination Complexes
  • Platinum Compounds
  • Platinum
  • Cisplatin